LEADER 03510nam 2200649 a 450 001 9910964134603321 005 20251017110058.0 010 $a9786610184194 010 $a9780309170390 010 $a0309170397 010 $a9781280184192 010 $a1280184191 010 $a9780309510943 010 $a0309510945 035 $a(CKB)111069351124294 035 $a(OCoLC)52859041 035 $a(CaPaEBR)ebrary10032372 035 $a(SSID)ssj0000220321 035 $a(PQKBManifestationID)11185168 035 $a(PQKBTitleCode)TC0000220321 035 $a(PQKBWorkID)10143817 035 $a(PQKB)11012000 035 $a(MiAaPQ)EBC3375183 035 $a(Perlego)4733854 035 $a(DNLM)1135550 035 $a(BIP)7443551 035 $a(EXLCZ)99111069351124294 100 $a20020218d2001 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aPerspectives on the Department of Defense Global Emerging Infections Surveillance and Response System $ea program review /$fPhilip S. Brachman, Heather C. O'Maonaigh, and Richard N. Miller, editors ; Committee to Review the Department of Defense Global Emerging Infections Surveillance and Response System, Medical Follow-Up Agency, Institute of Medicine 205 $a1st ed. 210 $aWashington, D.C. $cNational Academy Press$d2001 215 $a1 online resource (214 pages) 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a9780309076357 311 08$a0309076358 320 $aIncludes bibliographical references (p. 177-185). 327 $aFront Matter -- Preface -- Reviewers -- Contents -- Acronyms and Abbreviations -- GEIS Maps -- Executive Summary -- 1 Introduction -- 2 GEIS at Naval Medical Research Center Detachment, Peru -- 3 GEIS at Naval Medical Research Unit 2, Indonesia -- 4 GEIS at the Armed Forces Research Institute of Medical Sciences, Thailand -- 5 GEIS at Naval Medical Research Unit 3, Egypt -- 6 GEIS at U.S. Army Medical Research Unit, Kenya -- 7 GEIS Central Hub and Military Health System Activities -- 8 Summary Conclusions and Recommendations -- References -- Appendix Committee Member and Staff Biographical Summaries. 330 $aPerspectives on the Department of Defense Global Emerging Infections Surveillance and Response System: A Program Review describes the capacity, quality, and effectiveness of the international and domestic facilities and programs that are a part of a DoD system to monitor and address emerging infectious diseases globally. The committee concludes that the goals of the system are in U.S. military, U.S. civilian, and global public health interests and that substantial progress has been made toward achieving system goals. 606 $aCommunicable diseases$xEpidemiology 615 0$aCommunicable diseases$xEpidemiology. 676 $a616.5 701 $aBrachman$b Philip S$01806250 701 $aO'Maonaigh$b Heather$01806251 701 $aMiller$b Richard N$g(Richard Nicholas)$0282125 712 02$aInstitute of Medicine (U.S.).$bCommittee to Review the Department of Defense Global Emerging Infections Surveillance and Response System. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910964134603321 996 $aPerspectives on the Department of Defense Global Emerging Infections Surveillance and Response System$94355323 997 $aUNINA